Therapy and Further Development of Anti-Leishmanial Drugs

Publisher： Bentham Science Publishers

E-ISSN： 2212-3903|3|3|204-208

ISSN： 1574-8855

Source： Current Drug Therapy, Vol.3, Iss.3, 2008-09, pp. : 204-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Therapy with Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis

By Garrood T.   Scott D.L.  

BioDrugs, Vol. 15, Iss. 8, 2001-08 ,pp. : 543-561

Adis International

Access to resources Recommend Favorite

Recommandations pour le développement des médicaments anti-ostéoporotiques: Guidelines for the Development of Anti-Osteoporotic Drugs

By Avouac Bernard  

Therapie, Vol. 58, Iss. 5, 2003-01 ,pp. : 421-424

Adis International

Access to resources Recommend Favorite

Complications of Anti-Vascular Endothelial Growth Factor Drugs

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 131-137

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Mitosis for Anti-Cancer Therapy

By Sudakin Valery  

BioDrugs, Vol. 21, Iss. 4, 2007-01 ,pp. : 225-233

Adis International

Access to resources Recommend Favorite

New anti-epileptic drugs: overcoming the limits of randomised controlled trials

By Brigo Francesco  

International Journal of Evidence-based Healthcare, Vol. 9, Iss. 4, 2011-12 ,pp. : 440-443

Blackwell Publishing

Access to resources Recommend Favorite